インプラント周囲炎市場-世界の産業規模、シェア、動向、機会、予測、2018～2028年、タイプ別、エンドユーザー別、地域別、競合

世界のインプラント周囲炎市場は、2022年に9億3,840万米ドルと評価され、2028年までのCAGRは8.20%で、予測期間中に目覚ましい成長を遂げると予測されています。

インプラント周囲炎は、歯科インプラント周囲の組織に影響を及ぼす炎症性疾患です。インプラント周囲炎は、天然歯の周囲組織を侵す炎症性疾患である歯周炎に類似しています。インプラント周囲炎は、特にインプラント周囲の軟組織と硬組織に炎症と感染を引き起こし、放置するとインプラントを支える骨が徐々に失われ、インプラントが機能しなくなる可能性があります。インプラント周囲炎の一般的な徴候や症状には、歯茎からの出血、腫れ、発赤、膿の排出、インプラント周囲の痛みや不快感、インプラントの可動性や緩み、進行したケースでは、目に見える歯茎の退縮やインプラントの糸の露出などがあります。インプラント周囲炎を発症するリスクを高める要因には、口腔衛生状態の悪化、喫煙、歯周病（歯肉疾患）の既往歴、糖尿病、特定の薬、定期的な歯科検診やメンテナンスの不足などがあります。インプラント周囲炎は、インプラント周囲の組織や骨の損失の程度によって、軽度から重度までの段階に分類されることが多いです。インプラント周囲炎を効果的に管理するためには、早期発見と介入が重要です。

世界の高齢化社会では、歯を失いインプラント治療を希望する人が増えています。高齢者人口の増加に伴い、インプラント周囲炎治療の需要は増加すると予想されます。歯科インプラント材料、診断ツール、および治療方法の継続的な進歩により、インプラント周囲炎管理の有効性が向上しています。こうした技術革新は、患者と医療専門家の双方を魅了しています。口腔の健康やインプラント周囲炎に関連するリスクに対する患者の意識が高まり、早期診断・早期治療につながっています。歯科医療従事者も予防措置を促進するために患者教育に力を入れています。歯科インプラントメーカーやプロバイダー間の激しい競合が、製品開発や治療プロトコルの革新を促しています。このような競争により、インプラント周囲炎管理の選択肢が広がります。効果的なインプラント周囲炎治療による患者の良好な転帰と歯科インプラントの保存は、患者の満足度に貢献し、このようなサービスの需要を促進します。

主な市場促進要因

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別（非外科、外科）
  • エンドユーザー別（歯科医院、病院）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 アジア太平洋のインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのインプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 製品上市
• 合併と買収

第13章 世界のインプラント周囲炎市場のSWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTLE分析

第16章 競合情勢

• Pfizer Inc.
• Cadila Pharmaceuticals Ltd.
• R.N. Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd.
• Prachi Pharmaceuticals Private Limited.
• Geistlich Pharma Inc.
• Healthy Life Pharma Pvt Ltd.

第17章 戦略的提言

第18章 調査会社・免責事項

Global Peri-implantitis Market has valued at USD 938.40 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.20% through 2028. Peri-implantitis is an inflammatory condition that affects the tissues surrounding dental implants. It is somewhat analogous to periodontitis, which is an inflammatory disease that affects the tissues surrounding natural teeth. Peri-implantitis specifically involves the inflammation and infection of the soft and hard tissues around a dental implant, which can lead to progressive loss of supporting bone and potentially result in implant failure if left untreated. Common signs and symptoms of peri-implantitis may include bleeding gums, swelling, redness, pus discharge, pain or discomfort around the implant, mobility or loosening of the implant, and, in advanced cases, visible gum recession and exposed implant threads. Several factors can increase the risk of developing peri-implantitis, including poor oral hygiene, smoking, a history of periodontal disease (gum disease), diabetes, certain medications, and a lack of regular dental check-ups and maintenance. Peri-implantitis is often categorized into stages, ranging from mild to severe, based on the extent of tissue and bone loss around the implant. Early detection and intervention are crucial for managing peri-implantitis effectively.

The global aging population is more likely to experience tooth loss and seek dental implant procedures. As the elderly population grows, the demand for peri-implantitis treatment is expected to increase. Ongoing advancements in dental implant materials, diagnostic tools, and treatment modalities have improved the effectiveness of peri-implantitis management. These technological innovations attract both patients and healthcare professionals. Increased awareness among patients about oral health and the risks associated with peri-implantitis has led to earlier diagnosis and treatment. Dental professionals are also focusing on patient education to promote preventive measures. Intense competition among dental implant manufacturers and providers is driving innovation in product development and treatment protocols. This competition can result in a wider array of options for peri-implantitis management. Positive patient outcomes and the preservation of dental implants through effective peri-implantitis treatment contribute to patient satisfaction and drive demand for such services.

Key Market Drivers

Technological Advancements

High-resolution imaging technologies such as cone-beam computed tomography (CBCT) and 3D scanning have become essential tools for diagnosing peri-implantitis. These techniques provide detailed visualizations of the implant and surrounding tissues, aiding in accurate diagnosis and treatment planning. Research was ongoing to identify specific biomarkers in saliva and peri-implant crevicular fluid that could indicate the presence of peri-implantitis. Such biomarkers could lead to early detection and monitoring of the condition. Digital impressions and intraoral scanning technologies have improved the precision and efficiency of dental implant procedures, including those for peri-implantitis treatment. Laser technologies, such as diode lasers and erbium lasers, have been used in the treatment of peri-implantitis. Laser therapy can remove infected tissue, disinfect the implant surface, and promote tissue regeneration.

Researchers have been developing antimicrobial coatings for dental implants to reduce the risk of peri-implantitis. These coatings release antimicrobial agents to inhibit bacterial growth around the implant. Guided Bone Regeneration (GBR) techniques involve the use of specialized membranes and graft materials to regenerate bone and soft tissue around dental implants affected by peri-implantitis. Advanced materials and surgical approaches have improved the effectiveness of GBR. Telehealth platforms and teledentistry services have become more widely adopted, allowing for remote consultations, monitoring, and follow-up care for patients with peri-implantitis. These technologies enhance access to specialized care. Computer-Aided Design and Manufacturing (CAD/CAM) technology has been utilized to create precise surgical guides for implant placement and to design custom implant abutments for better fit and esthetics. Ultrasonic devices designed for implant maintenance and cleaning have been developed. These devices use ultrasonic vibrations to remove biofilm and calculus from implant surfaces without damaging the implant. Research into smart implants with integrated sensors and monitoring capabilities has been ongoing. These implants could provide real-time data on the health of the implant and surrounding tissues, allowing for early detection of issues like peri-implantitis. Advances in biomaterials, such as growth factors and tissue engineering scaffolds, have been explored to enhance tissue regeneration in peri-implantitis treatment. Artificial intelligence and machine learning algorithms have been applied to predict the risk of peri-implantitis and develop personalized treatment plans based on patient-specific data. This factor will help in the development of the Global Peri-implantitis Market.

Rising Aging Population

With age, individuals are more likely to experience tooth loss due to factors such as gum disease, decay, and wear and tear. As a result, they may seek tooth replacement options, including dental implants, which can be susceptible to peri-implantitis. Older individuals who have lost teeth may opt for dental implant procedures as a more permanent and functional solution compared to traditional dentures. This trend leads to a higher number of dental implants being placed, increasing the pool of individuals at risk of peri-implantitis. Dental implants, like natural teeth, can deteriorate over time. As the population of individuals with dental implants ages, there is a higher likelihood of implants experiencing complications, including peri-implantitis. Older individuals are more likely to have chronic health conditions, such as diabetes and heart disease, which can increase the risk of peri-implantitis. These conditions may affect the body's ability to fight infections and maintain oral health.

Older patients with dental implants often require regular follow-up appointments and maintenance to monitor their oral health and address any issues promptly. This ongoing care contributes to the demand for peri-implantitis management services. Older individuals tend to be more proactive about their health and may seek dental care, including peri-implantitis treatment, to maintain their quality of life and oral function. Advances in healthcare have led to longer life expectancy. As people live longer, there is a greater likelihood of requiring dental implants and subsequently needing peri-implantitis treatment in their later years. Dental implants can significantly improve the quality of life for older individuals by restoring their ability to eat, speak, and smile comfortably. This motivates older adults to pursue dental implant procedures and, by extension, peri-implantitis management. This factor will pace up the demand of the Global Peri-implantitis Market.

Increasing Awareness and Education

Awareness campaigns and educational efforts can help individuals recognize the signs and symptoms of peri-implantitis at an early stage. When people are informed about the condition, they are more likely to seek professional dental care if they experience any concerning symptoms, such as bleeding gums, inflammation, or discomfort around dental implants. Education can promote preventive measures to reduce the risk of peri-implantitis. Patients who understand the importance of proper oral hygiene, regular dental check-ups, and implant maintenance are more likely to take steps to prevent peri-implantitis from developing in the first place.

Educated patients are more likely to follow their dentist's recommendations for post-implant care and maintenance. This can include regular dental cleanings, implant examinations, and adherence to oral hygiene practices that reduce the risk of peri-implantitis. Patients who are well-informed about the risks and benefits of dental implants are more likely to make informed decisions regarding implant placement and maintenance. They may also be more receptive to additional treatments if peri-implantitis is diagnosed. Education efforts can improve overall oral health literacy, making individuals more aware of the importance of oral health for their overall well-being. This can lead to a greater appreciation for dental implant procedures and their long-term implications. Some individuals may be hesitant to seek dental care or report peri-implantitis symptoms due to fear or stigma. Education can help reduce this stigma, encouraging individuals to seek timely treatment when needed. Awareness and education efforts are not limited to patients; they also target dental professionals. Dentists, oral surgeons, and dental hygienists who are well-informed about peri-implantitis are more likely to diagnose the condition accurately and provide appropriate treatment recommendations. Patients who are educated about peri-implantitis may become advocates for their own oral health and raise awareness among their peers and within their communities. This can lead to a positive ripple effect in terms of demand for peri-implantitis care. As awareness of peri-implantitis increases, the demand for related products and services, including diagnostic tools, treatment modalities, and maintenance products, is likely to grow. This can stimulate market expansion and innovation. This factor will accelerate the demand of the Global Peri-implantitis Market.

Key Market Challenges

Cost of Treatment

Peri-implantitis treatment can be costly, particularly in cases where surgical interventions, such as open flap debridement, bone grafting, or implant removal and replacement, are required. The expenses associated with these procedures, including professional fees, facility charges, and post-operative care, can add up quickly. Dental insurance plans often do not provide comprehensive coverage for peri-implantitis treatment. This lack of coverage can place a significant financial burden on patients, making treatment less accessible. Many peri-implantitis treatment expenses are out-of-pocket costs for patients. This includes the cost of diagnostic tests, consultations with specialists, surgical procedures, medications, and follow-up care. Peri-implantitis treatment may require multiple treatment sessions and follow-up appointments, which can further increase the overall cost for patients. The cost of peri-implantitis treatment can vary widely depending on the severity of the condition, the complexity of the procedures required, the geographic location of the dental practice, and the expertise of the treating professionals. Patients with limited financial resources may find it challenging to afford the upfront costs associated with peri-implantitis treatment. This can lead to delays in seeking care or a reluctance to pursue treatment altogether. High treatment costs can have a significant impact on the quality of life of patients with peri-implantitis. They may have to make difficult choices between their oral health and other essential expenses. Patients in underserved or remote areas may have limited access to specialized dental professionals with expertise in peri-implantitis treatment. Traveling long distances to seek care can add to the overall cost.

Implant Longevity

Peri-implantitis is characterized by bacterial infection and inflammation around the implant site. If not effectively treated, this can lead to bone loss and implant instability, ultimately resulting in implant failure. Peri-implantitis can lead to progressive bone loss around the implant, which can weaken the implant's anchorage. Over time, extensive bone resorption may make it impossible to maintain implant stability. Successful osseointegration, the integration of the implant with the surrounding bone, is essential for implant stability and longevity. Peri-implantitis can disrupt osseointegration and compromise the implant's long-term performance. As peri-implantitis progresses, patients may experience implant mobility, which is a clear sign of implant instability. Mobile implants are at high risk of failure and may need to be removed. In severe cases of peri-implantitis, implant removal may be necessary to prevent further complications. This not only results in the loss of the implant but also necessitates additional costs for implant replacement. Even after successful peri-implantitis treatment, patients remain at risk of recurrent infections. This can lead to a cycle of treatment and reinfection, compromising implant longevity. Patients with chronic diseases such as diabetes or autoimmune disorders may have compromised immune systems, making them more susceptible to peri-implantitis and implant complications. The long-term success of dental implants depends on patients' commitment to oral hygiene and maintenance, including regular dental check-ups. Non-compliance with post-implant care recommendations can negatively impact implant longevity.

Key Market Trends

Treatment Modalities

Surgical treatment modalities, such as open flap debridement, bone grafting, and guided tissue regeneration, continue to be prominent in peri-implantitis management. Advancements in surgical techniques and materials enhance their effectiveness. Laser technology, including diode lasers and erbium lasers, has gained popularity for the treatment of peri-implantitis. Lasers can effectively remove infected tissue, disinfect implant surfaces, and promote tissue regeneration. Various antimicrobial agents, including topical antibiotics and antiseptics, are used in the treatment of peri-implantitis to control bacterial infections. Research is ongoing to develop more targeted and effective antimicrobial treatments. Implantoplasty involves the mechanical smoothing of rough implant surfaces to remove biofilm and encourage re-osseointegration. This minimally invasive approach is gaining attention as a potential treatment option. Non-surgical modalities, such as mechanical debridement and air abrasive therapy, are considered for less severe cases of peri-implantitis. These methods aim to remove biofilm and calculus without the need for surgical intervention. Personalized treatment plans based on the specific needs of each patient are becoming more common. This includes considering factors like the extent of tissue loss, bone quality, and patient health status. Biomaterials, growth factors, and tissue engineering scaffolds are being explored to enhance tissue regeneration around dental implants affected by peri-implantitis. Telehealth platforms and teledentistry services are being utilized for remote consultations, monitoring, and follow-up care, making peri-implantitis treatment more accessible to patients. Research into smart implants with integrated sensors and monitoring capabilities is ongoing. These implants may provide real-time data on the health of the implant and surrounding tissues, aiding in treatment decisions.

Segmental Insights

Type Insights

In 2022, the Global Peri-implantitis Market largest share was held by Surgical segment and is predicted to continue expanding over the coming years. Peri-implantitis is a complex condition that often requires surgical intervention for effective treatment. Surgical procedures may include open flap debridement, bone grafting, implantoplasty (smoothing of implant surfaces), and even implant removal in severe cases. These surgical techniques are often necessary to remove infected tissues, promote tissue regeneration, and salvage failing dental implants. Surgical treatment for peri-implantitis demands specialized expertise in oral surgery and implantology. Oral surgeons, periodontists, and implant specialists are typically the professionals who perform these surgical procedures. They have the necessary training and skills to address the challenges presented by peri-implantitis. Patients with advanced stages of peri-implantitis, where significant tissue and bone loss have occurred, may require surgical intervention. This patient population contributes to the demand for surgical treatments and the prominence of the surgical segment in the market. Surgical techniques often involve regenerative procedures, such as bone grafting and guided tissue regeneration, which are crucial for restoring lost supporting structures around the dental implant. These procedures are typically performed in surgical settings.

End-User Insights

In 2022, the Global Peri-implantitis Market largest share was held by Hospitals segment in the forecast period and is predicted to continue expanding over the coming years. Peri-implantitis, which is an inflammatory condition affecting dental implants, often requires specialized and complex treatment. Hospitals, particularly those with dental departments or oral surgery units, are well-equipped to provide a wide range of dental services, including surgical procedures, which may be necessary for the treatment of peri-implantitis. Hospitals typically have a pool of specialized dental professionals, including oral surgeons, periodontists, and prosthodontists, who are trained to diagnose and treat peri-implantitis effectively. These specialists can provide comprehensive care for patients with peri-implantitis, from diagnosis to treatment and follow-up. In some instances, peri-implantitis can lead to acute complications that require emergency care. Hospitals are equipped to handle emergency cases, providing timely treatment to prevent further complications. Hospitals can offer both inpatient and outpatient services, making them suitable for managing a wide range of peri-implantitis cases. Severe cases may require hospitalization, while less severe cases can be managed on an outpatient basis.

Regional Insights

The North America region dominates the Global Peri-implantitis Market in 2022. North America, particularly the United States and Canada, had a high prevalence of dental implant procedures. The region's well-developed healthcare infrastructure and a relatively high standard of living contributed to the popularity of dental implants as a restorative dental solution. The aging population in North America was a significant driver of dental implant procedures. Older individuals are more likely to experience tooth loss and seek dental implants as a replacement option. North America is home to many leading dental implant manufacturers and research institutions. Ongoing technological advancements in dental implant materials and techniques, including those aimed at preventing and treating peri-implantitis, often originate in this region. In some parts of North America, dental insurance coverage is relatively common, making it more affordable for patients to undergo dental implant procedures and related treatments, including those for peri-implantitis.

Key Market Players

Pfizer Inc.,

Cadila Pharmaceuticals Ltd.

R.N. Laboratories Pvt. Ltd.

Basic Pharma Life Science Pvt. Ltd

Prachi Pharmaceuticals Private Limited

Geistlich Pharma Inc.

Healthy Life Pharma

Report Scope:

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peri-implantitis Market, By Type:

• Non-Surgical
• Antibiotics
• Laser Debridement
• Mechanical Debridement
• Surgical
• Bone Regeneration
• Implanto-Plasty
• Open Flap Debridement

Peri-implantitis Market, By End-User:

• Dental Clinics
• Hospitals

Global Peri-implantitis Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

• Global Peri-implantitis Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peri-implantitis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Non-Surgical, Surgical)
  • 5.2.2. By End-User (Dental Clinics, Hospitals)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. Asia Pacific Peri-implantitis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Peri-implantitis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. India Peri-implantitis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Australia Peri-implantitis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Japan Peri-implantitis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End User
  • 6.3.5. South Korea Peri-implantitis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End User

7. Europe Peri-implantitis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Peri-implantitis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Peri-implantitis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Spain Peri-implantitis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Peri-implantitis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. United Kingdom Peri-implantitis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. North America Peri-implantitis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Peri-implantitis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Mexico Peri-implantitis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Canada Peri-implantitis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User

9. South America Peri-implantitis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Peri-implantitis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Peri-implantitis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Peri-implantitis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Peri-implantitis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Peri-implantitis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Peri-implantitis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Peri-implantitis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Peri-implantitis Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Pfizer Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Cadila Pharmaceuticals Ltd.
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. R.N. Laboratories Pvt. Ltd.
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. Basic Pharma Life Science Pvt. Ltd.
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Prachi Pharmaceuticals Private Limited.
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. Geistlich Pharma Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. Healthy Life Pharma Pvt Ltd.
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer